Literature DB >> 18761507

Pharma in the bedroom . . . and the kitchen. . . . The pharmaceuticalisation of daily life.

Nick J Fox1, Katie J Ward.   

Abstract

This paper examines the consequences of a new emphasis on lifestyle in the production, marketing and consumption of pharmaceuticals. Over the past decade, a range of medicines have become available that address aspects of lifestyle, while others have been the subject of lifestyle marketing. We argue, with recourse to a broad literature from the social sciences, economics and health services research and from our study of pharmaceutical consumption, that two processes can be discerned. First, there is a domestication of pharmaceutical consumption, with drugs available via home computers, and marketing of pharmaceuticals that focuses upon private or personal conditions and addresses domestic activities such as sex and cooking. Secondly, there is a pharmaceuticalisation of everyday life as the pharmaceutical industry introduces profitable medicines for a range of daily activities and pharmaceuticals come to be seen by consumers as a 'magic bullet' to resolve problems of daily life. We suggest that the pharmaceuticalisation of daily life links the economics and politics of pharmaceutical production to the private lives of citizens.

Mesh:

Substances:

Year:  2008        PMID: 18761507     DOI: 10.1111/j.1467-9566.2008.01114.x

Source DB:  PubMed          Journal:  Sociol Health Illn        ISSN: 0141-9889


  11 in total

1.  Academic doping or Viagra for the brain? The history of recreational drug use and pharmacological enhancement can provide insight into these uses of neuropharmaceuticals.

Authors:  Jayne C Lucke; Stephanie K Bell; Bradley J Partridge; Wayne D Hall
Journal:  EMBO Rep       Date:  2011-02-11       Impact factor: 8.807

2.  Towards a genealogy of pharmacological practice.

Authors:  Ricardo Camargo; Nicolás Ried
Journal:  Med Health Care Philos       Date:  2016-03

3.  Peering into the pharmaceutical "pipeline": investigational drugs, clinical trials, and industry priorities.

Authors:  Jill A Fisher; Marci D Cottingham; Corey A Kalbaugh
Journal:  Soc Sci Med       Date:  2014-08-19       Impact factor: 4.634

4.  Big Pharma: a former insider's view.

Authors:  David Badcott
Journal:  Med Health Care Philos       Date:  2013-05

5.  Measuring Exposure to Direct-to-Consumer Advertising-A Validation Study in the Context of Cancer-Related Treatment Advertising.

Authors:  Andy Sl Tan; Robert C Hornik
Journal:  Commun Methods Meas       Date:  2014-01-01

6.  A Pill for the Ill? Patients' Reports of Their Experience of the Medical Encounter in the Treatment of Depression.

Authors:  Andreas Vilhelmsson; Tommy Svensson; Anna Meeuwisse
Journal:  PLoS One       Date:  2013-06-18       Impact factor: 3.240

7.  International law, public health, and the meanings of pharmaceuticalization.

Authors:  Emilie Cloatre; Martyn Pickersgill
Journal:  New Genet Soc       Date:  2014-09-18

8.  What kind of 'a girls' thing'? Frictions and continuities in the framing and taming of the HPV vaccine in Finland.

Authors:  Mikko J Virtanen
Journal:  Sociol Health Illn       Date:  2019-04-03

9.  Self-Medication-Related Behaviors and Poland's COVID-19 Lockdown.

Authors:  Marta Makowska; Rafał Boguszewki; Michał Nowakowski; Monika Podkowińska
Journal:  Int J Environ Res Public Health       Date:  2020-11-11       Impact factor: 3.390

Review 10.  Psychiatrization of Society: A Conceptual Framework and Call for Transdisciplinary Research.

Authors:  Timo Beeker; China Mills; Dinesh Bhugra; Sanne Te Meerman; Samuel Thoma; Martin Heinze; Sebastian von Peter
Journal:  Front Psychiatry       Date:  2021-06-04       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.